Terms: = Skin cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
4 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung cancer.
Dizier B; Callegaro A; Debois M; Dreno B; Hersey P; Gogas HJ; Kirkwood JM; Vansteenkiste JF; Sequist LV; Atanackovic D; Goeman J; van Houwelingen H; Salceda S; Wang F; Therasse P; Debruyne C; Spiessens B; Brichard VG; Louahed J; Ulloa-Montoya F
Clin Cancer Res; 2020 Apr; 26(7):1725-1735. PubMed ID: 31732522
[TBL] [Abstract] [Full Text] [Related]
3. Argon plasma coagulation of actinic keratoses imaged by optical coherence tomography: An in vivo study indicating a possible lesion-directed treatment.
Schmitz L; Hessam S; Scholl L; Reitenbach S; Segert MH; Gambichler T; Stockfleth E; Bechara FG
J Biophotonics; 2018 Oct; 11(10):e201800075. PubMed ID: 29893051
[TBL] [Abstract] [Full Text] [Related]
4. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract] [Full Text] [Related]
